Kymera Therapeutics (KYMR) Stock Price & Financial Analysis
Kymera Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Kymera Therapeutics
What is the current stock price for KYMR?
As of the latest trading session, KYMR stock trades at $87.44. The 52-week range is $36.65–$103.00, with a day range of $84.52–$88.09.
What is the P/E ratio for KYMR?
The P/E ratio (Price-to-Earnings) for KYMR is shown in the Key Statistics section. This valuation metric helps compare Kymera Therapeutics, Inc. to industry peers.
Does KYMR pay dividends?
Kymera Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for KYMR?
Analyst ratings and recommendations for KYMR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of KYMR?
Kymera Therapeutics's market capitalization is $8.53B, classifying it as a mid-cap company. Kymera Therapeutics operates in the Healthcare sector within the Biotechnology industry.